2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician NPI 1861657108 MD
Verify on CMS →

BILAL CHUGHTAI, MD

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 350 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician avg: 1K
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$87.0K
138 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: BILAL CHUGHTAI, MD is a Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 1K claims across 350 beneficiaries — 28% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $87.0K across 138 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: BILAL CHUGHTAI, MD reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 1,430 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

BILAL CHUGHTAI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

BILAL CHUGHTAI, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/25/2008

NPI 1861657108

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician

Rare

109 US NPIs in this specialty

Medicare Part D claims

1,430 30% vs specialty avg

2023 prescription claims

Specialty avg: 1,103

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician compares to other specialties among New York providers

New York providers

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician share within New York

1. Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician share within New York

Medicare quality performance — MIPS

BILAL CHUGHTAI, MD's 2023 MIPS final score plotted against the Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BILAL CHUGHTAI, MD is a Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1861657108. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

BILAL CHUGHTAI, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider holding MD credentials at 425 E 61ST ST FL 12, NEW YORK, NY, 10065, with a listed phone of (646) 962-4811. NPI 1861657108 was issued on 07/25/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHUGHTAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,430 prescription claims written by this provider, covering 350 Medicare beneficiaries and totaling roughly $386K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8066), compared with the national average of 83.1.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician is a narrow specialty nationwide, with 109 enrolled providers across 28 states and an average of 1,103 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

425 E 61ST ST FL 12
NEW YORK, NY 10065

Provider Details

NPI 1861657108
Specialty Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
Credentials MD
Gender Male
NPI Issued 07/25/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
86.8066
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where BILAL CHUGHTAI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NORTH SHORE-LIJ MEDICAL PC
SYOSSET, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BILAL CHUGHTAI, MD. Source: openpaymentsdata.cms.gov.

Total received

$87.0K

Largest payer

Olympus Corporation of the Americas

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to BILAL CHUGHTAI, MD. To verify BILAL CHUGHTAI, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

BILAL CHUGHTAI, MD — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 1,430 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,430
Total Claims
$386K
Total Drug Cost
350
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,086
Total Day Supply
89,231
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$329K
Generic Drug Cost
$57K
Antibiotic Claims
120

Patient Demographics

Average Patient Age
76.9 years
Avg HCC Risk Score
1.33
Gender Split
33% female / 67% male
Age Distribution
<65: 15, 65-74: 123, 75-84: 151, 85+: 61

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
238
Myrbetriq
Mirabegron
171
Finasteride
164
Gemtesa
Vibegron
137
Methenamine Hippurate
104
Estradiol
77
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
50
Alfuzosin Hcl Er
Alfuzosin Hcl
46
Tadalafil
45
Dutasteride
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Overview

How BILAL CHUGHTAI, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician landscape nationally.

109
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in US
28
States with Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
1,103
Avg Claims per Provider

BILAL CHUGHTAI, MD's 1,430 claims are above the specialty average of 1,103.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CHUGHTAI.

Compare Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BILAL CHUGHTAI, MD's specialty?
BILAL CHUGHTAI, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician and practices in NEW YORK, New York. Credentials: MD.
How much does BILAL CHUGHTAI, MD prescribe under Medicare Part D?
In 2023, BILAL CHUGHTAI, MD wrote 1,430 Medicare Part D claims totaling $386K in drug costs for 350 beneficiaries.
What is BILAL CHUGHTAI, MD's Medicare quality score?
BILAL CHUGHTAI, MD has a CMS MIPS Final Score of 100/100 (Quality: 86.8066). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BILAL CHUGHTAI, MD located?
BILAL CHUGHTAI, MD is located at 425 E 61ST ST FL 12, NEW YORK, NY, 10065. Phone: (646) 962-4811.
What is BILAL CHUGHTAI, MD's NPI number?
BILAL CHUGHTAI, MD's National Provider Identifier (NPI) is 1861657108, issued on 07/25/2008.
Does BILAL CHUGHTAI, MD prescribe more brand-name or generic drugs?
BILAL CHUGHTAI, MD's prescribing is 28% brand-name and 72% generic drugs by claim count, with $329K in brand drug costs.
How many Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers are there in the US?
There are 109 Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers across 28 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider writes 1,103 Medicare Part D claims per year.
What drugs does BILAL CHUGHTAI, MD prescribe most often?
Based on 2023 Medicare Part D data, BILAL CHUGHTAI, MD's most frequently prescribed drugs include Tamsulosin Hcl, Myrbetriq, Finasteride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BILAL CHUGHTAI, MD accept Medicare?
BILAL CHUGHTAI, MD appears in CMS Medicare data with 1,430 Part D claims and 350 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BILAL CHUGHTAI, MD's credentials?
BILAL CHUGHTAI, MD's NPI is 1861657108 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology